Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M17,262Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M414EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)18.2Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %2.7PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M100,000,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with VEU

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

VEU is held by these investors:

VEU: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.48415.08view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.94188.25view
Dinwoodie, Tyler Wayne PaulSenior Officer 2017-01-16Buy4,000$0.1728623.53view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.363490.44view
Bebek, IvanDirector 2017-01-16Buy8,990$3.381344.67view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.4111809.76view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.9174.96view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.27678.79view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.38-19.13view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.1532453.33view

Quarterly/Annual Reports about VEU:

    News about VEU:

    Articles On GuruFocus.com
    What A Wonderful Market (And Where This Leads Us) Jul 07 2014 

    More From Other Websites
    French Election: Is the Protectionist Agenda Still in Play? Apr 27 2017
    Why AstraZeneca Could See Lower Revenues in 1Q17 Apr 26 2017
    The Syria Conundrum: Is Turkey with the US or Russia? Apr 21 2017
    China’s Manufacturing Sector and Rising Industrial Production in 2017 Apr 19 2017
    Trump’s Role in the Market’s Current Guessing Game Apr 19 2017
    How the Economy and Markets Could React to Tax Reforms Apr 05 2017
    Zacks Podcast Highlights: Are U.S. Investors Focused on the Wrong Markets Right Now? Apr 04 2017
    Investigational Breast Cancer Drug Could Boost Novartis’s Position Apr 03 2017
    Will Novartis’s Alcon Business See Growth in 2017? Apr 03 2017
    Novartis Has Developed a Robust Innovation Strategy Mar 31 2017
    An Aggressive Retirement Saver Portfolio for ETF Investors Mar 31 2017
    Novartis’s Cosentyx Managed to Achieve Blockbuster Status in 2016 Mar 29 2017
    With low yields abroad, investors hunt for international dividend funds Mar 28 2017
    Japan’s Manufacturing PMI Is Weakening: What It Means for the Economy Mar 28 2017
    Exploring Novartis’s 2016 Revenue Mar 24 2017
    Will China’s Improved Industrial Production Impact Manufacturing? Mar 24 2017
    AstraZeneca Expects Fall in Net Profit Margins in 2017 Feb 28 2017
    Japan’s Manufacturing PMI Is Improving Feb 27 2017
    Teva Is Expected to Witness a Modest Revenue Rise in 2017 Feb 23 2017
    This Guy Built A Superdiversified Portfolio With 10 ETFs Feb 21 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)